Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


French urological device company deletes Europe market listing:

This article was originally published in Clinica

Executive Summary

An ongoing and "significant" decline in the liquidity of the ADSs of EDAP TMS has prompted the French producer of minimally invasive urological devices to seek delisting from Nasdaq Europe. The move, decided on February 11 and requested by the Vaulx-en-Velin company on February 28, will take place on April. The US Nasdaq listing will not be affected. CEO Eric Simon said that continued trading on the European Nasdaq did not add sufficient value for EDAP or its shareholders.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts